Elliptic Sets the Engineering Bar for On-Chain Risk With “Built for Compliance” Paper as New Rules Take Hold and Banks Launch a Joint Stablecoin October 1, 2026 Built for compliance arrives as crypto compliance rules tighten worldwide and a bank-led stablecoin enters the market
KBRA Releases Research – European CLO Manager Style Comparisons: September 2026 Update October 1, 2026 KBRA releases a report comparing European broadly syndicated loan (BSL) collateralised loan obligation (CLO) managers across a KBRA-defined set of standardised portfolio metrics, including credit quality as measured by KBRA Weighted Average Rating Factor (K-WARF), weighted average spread (WAS), equity returns, leverage, and collateral characteristics. The analysis covers 67 managers across 767 BSL transactions, representing [...]
Lloyds CMO: Uncertainty is the price of an interesting career October 1, 2026 We dig into the memory bank of the City's great and good. Today, Suresh Balaji, chief marketing office at Lloyds, takes us through his career.
Dispatch: Discos and despair at the Labour Party Conference October 1, 2026 Labour conference parties, the Guinness revolution and the triple lock kibosh; catch up on the latest gossip in The Capitalist.
Telekom Srbija (Group) Is Building City-Scale Digital Infrastructure for EXPO 2027 October 1, 2026 On a site that will function, in terms of capacity, as an entirely new urban district, with more than 46 kilometres of fibre-optic network, 35 radio sites, 5G Standalone and Wi-Fi 7, Telekom Srbija Group is presenting the digital ecosystem it is building for over 135 participating countries and four million expected visitors. Telekom Srbija sees EXPO 2027 as a platform for strengthening its global positioning and marketing its products and services.
EADV 2026: Long-Term Disease Control for up to Five Years in Patients With Moderate-to-Severe Atopic Dermatitis Treated With Lebrikizumab October 1, 2026 Late-breaking results from the Phase 3b ADlong clinical study presented by Almirall at EADV 2026 show treatment outcomes over time with up to five years of lebrikizumab treatment in moderate-to-severe atopic dermatitis: sustained efficacy and safety demonstrated by 92.9% of patients achieving EASI-75 and 73.8% achieving EASI-90 at the end of the study (week 108)1. At week 108 of continuous treatment, 66.7% of patients achieved clear or almost-clear skin, while 78.0% reported an absolute pruritus score of four or less on the Pruritus Numerical Rating Scale1, indicating low levels of itch, one of the most bothersome symptoms for patients. The ADlong study reflects the ongoing commitment to generating long-term evidence for lebrikizumab and the opportunity to achieve long-term disease control in AD treatment. Almirall’s scientific presence at EADV 2026 includes more than 20 abstracts across atopic dermatitis, psoriasis and actinic keratosis, alongside three expert-led events: two symposia and an interactive AD Morning Hub.
Ares Strengthens Commitment to Plenitude Through €1 Billion Capital Contribution October 1, 2026 Reorganization of Plenitude’s capital structure expands Ares’ economic and governance participation in the company
Orifarm Unveils 2031 Strategy to Accelerate Growth Across Europe, With Significant Expansion in Generics October 1, 2026 With its five-year strategy, Fit to Scale, Orifarm sets out an ambitious path to scale across Europe, including a major expansion of its prescription medicines business from a Nordic footprint to a broader European platform. The strategy aims to double EBITDA to €300m and generate more than €3bn in revenue by 2031, marking the next [...]
Alpine A390 GT review: a family-sized substitute for a sports car October 1, 2026 It’s been quite the year. I turned 30, got married and bought a house. As my wife promised, I could finally start saving for a silly car now the sensible purchases were done. As part of the DINKY (double income, no kids) brigade, I was getting excited while flicking through ads for sports cars. A [...]
The good news nobody will tell you: the Great Barrier Reef is refusing to die on schedule October 1, 2026 Despite the efforts of an entire PR industry built to predict its demise, the Great Barrier Reef is actually flourishing, says Bjorn Lomborg Australia’s marine scientists recently released their annual audit of the Great Barrier Reef, and it contains news you almost certainly haven’t heard: coral cover held steady or increased across most of the [...]